Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Affinity Chromatography Market

ID: MRFR/HC/27368-HCR
128 Pages
Rahul Gotadki
Last Updated: April 24, 2026

Affinity Chromatography Market Research Report By Product Type (Ligand Type, Matrix Type), By Application (Biomolecule Purification, Chromatographic Separation), By End User (Pharmaceutical and Biotechnology Companies, Research Institutes, Academic Institutions) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Affinity Chromatography Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Product Type (USD Billion)
  49.     4.1.1 Ligand Type
  50.     4.1.2 Matrix Type
  51.   4.2 Healthcare, BY Application (USD Billion)
  52.     4.2.1 Biomolecule Purification
  53.     4.2.2 Chromatographic Separation
  54.   4.3 Healthcare, BY End User (USD Billion)
  55.     4.3.1 Pharmaceutical and Biotechnology Companies
  56.     4.3.2 Research Institutes
  57.     4.3.3 Academic Institutions
  58.   4.4 Healthcare, BY Region (USD Billion)
  59.     4.4.1 North America
  60.       4.4.1.1 US
  61.       4.4.1.2 Canada
  62.     4.4.2 Europe
  63.       4.4.2.1 Germany
  64.       4.4.2.2 UK
  65.       4.4.2.3 France
  66.       4.4.2.4 Russia
  67.       4.4.2.5 Italy
  68.       4.4.2.6 Spain
  69.       4.4.2.7 Rest of Europe
  70.     4.4.3 APAC
  71.       4.4.3.1 China
  72.       4.4.3.2 India
  73.       4.4.3.3 Japan
  74.       4.4.3.4 South Korea
  75.       4.4.3.5 Malaysia
  76.       4.4.3.6 Thailand
  77.       4.4.3.7 Indonesia
  78.       4.4.3.8 Rest of APAC
  79.     4.4.4 South America
  80.       4.4.4.1 Brazil
  81.       4.4.4.2 Mexico
  82.       4.4.4.3 Argentina
  83.       4.4.4.4 Rest of South America
  84.     4.4.5 MEA
  85.       4.4.5.1 GCC Countries
  86.       4.4.5.2 South Africa
  87.       4.4.5.3 Rest of MEA
  88. 5 SECTION V: COMPETITIVE ANALYSIS
  89.   5.1 Competitive Landscape
  90.     5.1.1 Overview
  91.     5.1.2 Competitive Analysis
  92.     5.1.3 Market share Analysis
  93.     5.1.4 Major Growth Strategy in the Healthcare
  94.     5.1.5 Competitive Benchmarking
  95.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  96.     5.1.7 Key developments and growth strategies
  97.       5.1.7.1 New Product Launch/Service Deployment
  98.       5.1.7.2 Merger & Acquisitions
  99.       5.1.7.3 Joint Ventures
  100.     5.1.8 Major Players Financial Matrix
  101.       5.1.8.1 Sales and Operating Income
  102.       5.1.8.2 Major Players R&D Expenditure. 2023
  103.   5.2 Company Profiles
  104.     5.2.1 Thermo Fisher Scientific (US)
  105.       5.2.1.1 Financial Overview
  106.       5.2.1.2 Products Offered
  107.       5.2.1.3 Key Developments
  108.       5.2.1.4 SWOT Analysis
  109.       5.2.1.5 Key Strategies
  110.     5.2.2 GE Healthcare (GB)
  111.       5.2.2.1 Financial Overview
  112.       5.2.2.2 Products Offered
  113.       5.2.2.3 Key Developments
  114.       5.2.2.4 SWOT Analysis
  115.       5.2.2.5 Key Strategies
  116.     5.2.3 Merck KGaA (DE)
  117.       5.2.3.1 Financial Overview
  118.       5.2.3.2 Products Offered
  119.       5.2.3.3 Key Developments
  120.       5.2.3.4 SWOT Analysis
  121.       5.2.3.5 Key Strategies
  122.     5.2.4 Bio-Rad Laboratories (US)
  123.       5.2.4.1 Financial Overview
  124.       5.2.4.2 Products Offered
  125.       5.2.4.3 Key Developments
  126.       5.2.4.4 SWOT Analysis
  127.       5.2.4.5 Key Strategies
  128.     5.2.5 Agilent Technologies (US)
  129.       5.2.5.1 Financial Overview
  130.       5.2.5.2 Products Offered
  131.       5.2.5.3 Key Developments
  132.       5.2.5.4 SWOT Analysis
  133.       5.2.5.5 Key Strategies
  134.     5.2.6 F. Hoffmann-La Roche (CH)
  135.       5.2.6.1 Financial Overview
  136.       5.2.6.2 Products Offered
  137.       5.2.6.3 Key Developments
  138.       5.2.6.4 SWOT Analysis
  139.       5.2.6.5 Key Strategies
  140.     5.2.7 Pall Corporation (US)
  141.       5.2.7.1 Financial Overview
  142.       5.2.7.2 Products Offered
  143.       5.2.7.3 Key Developments
  144.       5.2.7.4 SWOT Analysis
  145.       5.2.7.5 Key Strategies
  146.     5.2.8 Sartorius AG (DE)
  147.       5.2.8.1 Financial Overview
  148.       5.2.8.2 Products Offered
  149.       5.2.8.3 Key Developments
  150.       5.2.8.4 SWOT Analysis
  151.       5.2.8.5 Key Strategies
  152.     5.2.9 Waters Corporation (US)
  153.       5.2.9.1 Financial Overview
  154.       5.2.9.2 Products Offered
  155.       5.2.9.3 Key Developments
  156.       5.2.9.4 SWOT Analysis
  157.       5.2.9.5 Key Strategies
  158.   5.3 Appendix
  159.     5.3.1 References
  160.     5.3.2 Related Reports
  161. 6 LIST OF FIGURES
  162.   6.1 MARKET SYNOPSIS
  163.   6.2 NORTH AMERICA MARKET ANALYSIS
  164.   6.3 US MARKET ANALYSIS BY PRODUCT TYPE
  165.   6.4 US MARKET ANALYSIS BY APPLICATION
  166.   6.5 US MARKET ANALYSIS BY END USER
  167.   6.6 CANADA MARKET ANALYSIS BY PRODUCT TYPE
  168.   6.7 CANADA MARKET ANALYSIS BY APPLICATION
  169.   6.8 CANADA MARKET ANALYSIS BY END USER
  170.   6.9 EUROPE MARKET ANALYSIS
  171.   6.10 GERMANY MARKET ANALYSIS BY PRODUCT TYPE
  172.   6.11 GERMANY MARKET ANALYSIS BY APPLICATION
  173.   6.12 GERMANY MARKET ANALYSIS BY END USER
  174.   6.13 UK MARKET ANALYSIS BY PRODUCT TYPE
  175.   6.14 UK MARKET ANALYSIS BY APPLICATION
  176.   6.15 UK MARKET ANALYSIS BY END USER
  177.   6.16 FRANCE MARKET ANALYSIS BY PRODUCT TYPE
  178.   6.17 FRANCE MARKET ANALYSIS BY APPLICATION
  179.   6.18 FRANCE MARKET ANALYSIS BY END USER
  180.   6.19 RUSSIA MARKET ANALYSIS BY PRODUCT TYPE
  181.   6.20 RUSSIA MARKET ANALYSIS BY APPLICATION
  182.   6.21 RUSSIA MARKET ANALYSIS BY END USER
  183.   6.22 ITALY MARKET ANALYSIS BY PRODUCT TYPE
  184.   6.23 ITALY MARKET ANALYSIS BY APPLICATION
  185.   6.24 ITALY MARKET ANALYSIS BY END USER
  186.   6.25 SPAIN MARKET ANALYSIS BY PRODUCT TYPE
  187.   6.26 SPAIN MARKET ANALYSIS BY APPLICATION
  188.   6.27 SPAIN MARKET ANALYSIS BY END USER
  189.   6.28 REST OF EUROPE MARKET ANALYSIS BY PRODUCT TYPE
  190.   6.29 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
  191.   6.30 REST OF EUROPE MARKET ANALYSIS BY END USER
  192.   6.31 APAC MARKET ANALYSIS
  193.   6.32 CHINA MARKET ANALYSIS BY PRODUCT TYPE
  194.   6.33 CHINA MARKET ANALYSIS BY APPLICATION
  195.   6.34 CHINA MARKET ANALYSIS BY END USER
  196.   6.35 INDIA MARKET ANALYSIS BY PRODUCT TYPE
  197.   6.36 INDIA MARKET ANALYSIS BY APPLICATION
  198.   6.37 INDIA MARKET ANALYSIS BY END USER
  199.   6.38 JAPAN MARKET ANALYSIS BY PRODUCT TYPE
  200.   6.39 JAPAN MARKET ANALYSIS BY APPLICATION
  201.   6.40 JAPAN MARKET ANALYSIS BY END USER
  202.   6.41 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE
  203.   6.42 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
  204.   6.43 SOUTH KOREA MARKET ANALYSIS BY END USER
  205.   6.44 MALAYSIA MARKET ANALYSIS BY PRODUCT TYPE
  206.   6.45 MALAYSIA MARKET ANALYSIS BY APPLICATION
  207.   6.46 MALAYSIA MARKET ANALYSIS BY END USER
  208.   6.47 THAILAND MARKET ANALYSIS BY PRODUCT TYPE
  209.   6.48 THAILAND MARKET ANALYSIS BY APPLICATION
  210.   6.49 THAILAND MARKET ANALYSIS BY END USER
  211.   6.50 INDONESIA MARKET ANALYSIS BY PRODUCT TYPE
  212.   6.51 INDONESIA MARKET ANALYSIS BY APPLICATION
  213.   6.52 INDONESIA MARKET ANALYSIS BY END USER
  214.   6.53 REST OF APAC MARKET ANALYSIS BY PRODUCT TYPE
  215.   6.54 REST OF APAC MARKET ANALYSIS BY APPLICATION
  216.   6.55 REST OF APAC MARKET ANALYSIS BY END USER
  217.   6.56 SOUTH AMERICA MARKET ANALYSIS
  218.   6.57 BRAZIL MARKET ANALYSIS BY PRODUCT TYPE
  219.   6.58 BRAZIL MARKET ANALYSIS BY APPLICATION
  220.   6.59 BRAZIL MARKET ANALYSIS BY END USER
  221.   6.60 MEXICO MARKET ANALYSIS BY PRODUCT TYPE
  222.   6.61 MEXICO MARKET ANALYSIS BY APPLICATION
  223.   6.62 MEXICO MARKET ANALYSIS BY END USER
  224.   6.63 ARGENTINA MARKET ANALYSIS BY PRODUCT TYPE
  225.   6.64 ARGENTINA MARKET ANALYSIS BY APPLICATION
  226.   6.65 ARGENTINA MARKET ANALYSIS BY END USER
  227.   6.66 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE
  228.   6.67 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
  229.   6.68 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
  230.   6.69 MEA MARKET ANALYSIS
  231.   6.70 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT TYPE
  232.   6.71 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
  233.   6.72 GCC COUNTRIES MARKET ANALYSIS BY END USER
  234.   6.73 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT TYPE
  235.   6.74 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
  236.   6.75 SOUTH AFRICA MARKET ANALYSIS BY END USER
  237.   6.76 REST OF MEA MARKET ANALYSIS BY PRODUCT TYPE
  238.   6.77 REST OF MEA MARKET ANALYSIS BY APPLICATION
  239.   6.78 REST OF MEA MARKET ANALYSIS BY END USER
  240.   6.79 KEY BUYING CRITERIA OF HEALTHCARE
  241.   6.80 RESEARCH PROCESS OF MRFR
  242.   6.81 DRO ANALYSIS OF HEALTHCARE
  243.   6.82 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  244.   6.83 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  245.   6.84 SUPPLY / VALUE CHAIN: HEALTHCARE
  246.   6.85 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
  247.   6.86 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
  248.   6.87 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  249.   6.88 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
  250.   6.89 HEALTHCARE, BY END USER, 2024 (% SHARE)
  251.   6.90 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
  252.   6.91 BENCHMARKING OF MAJOR COMPETITORS
  253. 7 LIST OF TABLES
  254.   7.1 LIST OF ASSUMPTIONS
  255.     7.1.1
  256.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  257.     7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  258.     7.2.2 BY APPLICATION, 2025-2035 (USD Billion)
  259.     7.2.3 BY END USER, 2025-2035 (USD Billion)
  260.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  261.     7.3.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  262.     7.3.2 BY APPLICATION, 2025-2035 (USD Billion)
  263.     7.3.3 BY END USER, 2025-2035 (USD Billion)
  264.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  265.     7.4.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  266.     7.4.2 BY APPLICATION, 2025-2035 (USD Billion)
  267.     7.4.3 BY END USER, 2025-2035 (USD Billion)
  268.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  269.     7.5.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  270.     7.5.2 BY APPLICATION, 2025-2035 (USD Billion)
  271.     7.5.3 BY END USER, 2025-2035 (USD Billion)
  272.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  273.     7.6.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  274.     7.6.2 BY APPLICATION, 2025-2035 (USD Billion)
  275.     7.6.3 BY END USER, 2025-2035 (USD Billion)
  276.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  277.     7.7.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  278.     7.7.2 BY APPLICATION, 2025-2035 (USD Billion)
  279.     7.7.3 BY END USER, 2025-2035 (USD Billion)
  280.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  281.     7.8.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  282.     7.8.2 BY APPLICATION, 2025-2035 (USD Billion)
  283.     7.8.3 BY END USER, 2025-2035 (USD Billion)
  284.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  285.     7.9.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  286.     7.9.2 BY APPLICATION, 2025-2035 (USD Billion)
  287.     7.9.3 BY END USER, 2025-2035 (USD Billion)
  288.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  289.     7.10.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  290.     7.10.2 BY APPLICATION, 2025-2035 (USD Billion)
  291.     7.10.3 BY END USER, 2025-2035 (USD Billion)
  292.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  293.     7.11.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  294.     7.11.2 BY APPLICATION, 2025-2035 (USD Billion)
  295.     7.11.3 BY END USER, 2025-2035 (USD Billion)
  296.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  297.     7.12.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  298.     7.12.2 BY APPLICATION, 2025-2035 (USD Billion)
  299.     7.12.3 BY END USER, 2025-2035 (USD Billion)
  300.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  301.     7.13.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  302.     7.13.2 BY APPLICATION, 2025-2035 (USD Billion)
  303.     7.13.3 BY END USER, 2025-2035 (USD Billion)
  304.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  305.     7.14.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  306.     7.14.2 BY APPLICATION, 2025-2035 (USD Billion)
  307.     7.14.3 BY END USER, 2025-2035 (USD Billion)
  308.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  309.     7.15.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  310.     7.15.2 BY APPLICATION, 2025-2035 (USD Billion)
  311.     7.15.3 BY END USER, 2025-2035 (USD Billion)
  312.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  313.     7.16.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  314.     7.16.2 BY APPLICATION, 2025-2035 (USD Billion)
  315.     7.16.3 BY END USER, 2025-2035 (USD Billion)
  316.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  317.     7.17.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  318.     7.17.2 BY APPLICATION, 2025-2035 (USD Billion)
  319.     7.17.3 BY END USER, 2025-2035 (USD Billion)
  320.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  321.     7.18.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  322.     7.18.2 BY APPLICATION, 2025-2035 (USD Billion)
  323.     7.18.3 BY END USER, 2025-2035 (USD Billion)
  324.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  325.     7.19.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  326.     7.19.2 BY APPLICATION, 2025-2035 (USD Billion)
  327.     7.19.3 BY END USER, 2025-2035 (USD Billion)
  328.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  329.     7.20.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  330.     7.20.2 BY APPLICATION, 2025-2035 (USD Billion)
  331.     7.20.3 BY END USER, 2025-2035 (USD Billion)
  332.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  333.     7.21.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  334.     7.21.2 BY APPLICATION, 2025-2035 (USD Billion)
  335.     7.21.3 BY END USER, 2025-2035 (USD Billion)
  336.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  337.     7.22.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  338.     7.22.2 BY APPLICATION, 2025-2035 (USD Billion)
  339.     7.22.3 BY END USER, 2025-2035 (USD Billion)
  340.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  341.     7.23.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  342.     7.23.2 BY APPLICATION, 2025-2035 (USD Billion)
  343.     7.23.3 BY END USER, 2025-2035 (USD Billion)
  344.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  345.     7.24.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  346.     7.24.2 BY APPLICATION, 2025-2035 (USD Billion)
  347.     7.24.3 BY END USER, 2025-2035 (USD Billion)
  348.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  349.     7.25.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  350.     7.25.2 BY APPLICATION, 2025-2035 (USD Billion)
  351.     7.25.3 BY END USER, 2025-2035 (USD Billion)
  352.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  353.     7.26.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  354.     7.26.2 BY APPLICATION, 2025-2035 (USD Billion)
  355.     7.26.3 BY END USER, 2025-2035 (USD Billion)
  356.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  357.     7.27.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  358.     7.27.2 BY APPLICATION, 2025-2035 (USD Billion)
  359.     7.27.3 BY END USER, 2025-2035 (USD Billion)
  360.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  361.     7.28.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  362.     7.28.2 BY APPLICATION, 2025-2035 (USD Billion)
  363.     7.28.3 BY END USER, 2025-2035 (USD Billion)
  364.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  365.     7.29.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  366.     7.29.2 BY APPLICATION, 2025-2035 (USD Billion)
  367.     7.29.3 BY END USER, 2025-2035 (USD Billion)
  368.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  369.     7.30.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  370.     7.30.2 BY APPLICATION, 2025-2035 (USD Billion)
  371.     7.30.3 BY END USER, 2025-2035 (USD Billion)
  372.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  373.     7.31.1
  374.   7.32 ACQUISITION/PARTNERSHIP
  375.     7.32.1

Healthcare Market Segmentation

Healthcare By Product Type (USD Billion, 2025-2035)

  • Ligand Type
  • Matrix Type

Healthcare By Application (USD Billion, 2025-2035)

  • Biomolecule Purification
  • Chromatographic Separation

Healthcare By End User (USD Billion, 2025-2035)

  • Pharmaceutical and Biotechnology Companies
  • Research Institutes
  • Academic Institutions

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions